ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $29,751,000 | -5.8% | 35,083,000 | 0.0% | 0.26% | +0.8% |
| Q3 2017 | $31,574,000 | +5.3% | 35,083,000 | 0.0% | 0.26% | -2.3% |
| Q2 2017 | $29,985,000 | +1.0% | 35,083,000 | 0.0% | 0.26% | +7.8% |
| Q1 2017 | $29,696,000 | +11.8% | 35,083,000 | 0.0% | 0.24% | -6.5% |
| Q4 2016 | $26,570,000 | -57.7% | 35,083,000 | -54.5% | 0.26% | -54.4% |
| Q3 2016 | $62,830,000 | -6.7% | 77,083,000 | 0.0% | 0.57% | -19.3% |
| Q2 2016 | $67,351,000 | -1.6% | 77,083,000 | 0.0% | 0.71% | -2.2% |
| Q1 2016 | $68,456,000 | +15.4% | 77,083,000 | +49.4% | 0.72% | +47.0% |
| Q4 2015 | $59,297,000 | +9.6% | 51,583,000 | -13.4% | 0.49% | -1.8% |
| Q3 2015 | $54,123,000 | -9.9% | 59,583,000 | 0.0% | 0.50% | -5.1% |
| Q2 2015 | $60,049,000 | -1.2% | 59,583,000 | 0.0% | 0.53% | +4.4% |
| Q1 2015 | $60,762,000 | -13.0% | 59,583,000 | -2.2% | 0.50% | -29.2% |
| Q4 2014 | $69,839,000 | +12.6% | 60,900,000 | +1.5% | 0.71% | -8.7% |
| Q3 2014 | $62,050,000 | – | 60,000,000 | – | 0.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 3,586,000 | $3,076,000 | 2.19% |
| Telemetry Investments, L.L.C. | 4,000,000 | $3,433,000 | 1.62% |
| Mohican Financial Management, LLC | 1,000,000 | $858,000 | 1.49% |
| Opera Trading Capital | 5,000,000 | $4,276,000 | 0.75% |
| SYMPHONY ASSET MANAGEMENT LLC | 6,060,000 | $5,231,000 | 0.59% |
| Castle Creek Arbitrage, LLC | 6,000,000 | $5,153,000 | 0.55% |
| SSI INVESTMENT MANAGEMENT LLC | 5,683,000 | $4,876,000 | 0.43% |
| CANYON CAPITAL ADVISORS LLC | 29,000,000 | $24,886,000 | 0.41% |
| IRON Financial LLC | 470,000 | $404,000 | 0.36% |
| Man Investments (CH) AG | 600,000 | $515,000 | 0.33% |